Greg Kidd, former chief risk officer at blockchain company Ripple, is acquiring a controlling stake in medical technology firm Known Labs. The deal, expected to close in the third quarter of this year, will see Kidd become CEO and chairman of the board. He will fund the purchase with 1,000 Bitcoin (roughly $105 million) and some cash. Known Labs intends to implement a Bitcoin treasury strategy, holding the cryptocurrency as core value for the company while maintaining its medical research division separate from this initiative. This strategy echoes the approach of Michael Saylor’s Bitcoin investment strategy at MicroStrategy. Notably, Kidd will hold 82% of Known Labs’ total market cap in Bitcoin. Ripple CEO Brad Garlinghouse recently advocated for industry unity and refrained from viewing Bitcoin community as an obstacle to XRP holders. Co-founder Chris Larsen also praised the progress toward environmentally responsible mining within Bitcoin. XRP benefits from growing corporate adoption.